News|Articles|September 9, 2025
EADV Congress 2025: Late-Breaking Trials Preview
Author(s)HCPLive Editorial Staff
Fact checked by: Tim Smith
A look at 13 phase 2 and phase 3 studies with significant implications from EADV 2025's late-breaking sessions.
Advertisement
Advertisement
Among dermatologists and other clinicians in the skin health space, the
Advertisement
Advertisement
